DDX17 and breast cancer: In addition, DDX5 and/or DDX17 are also involved in the alternative splicing of Caspase 9, mH2A1 (37), macroH2A1 (38), etc., which increased the malignancy of pancreatic ductal adenocarcinoma and breast cancer.